Loading clinical trials...
Loading clinical trials...
Prospective Open Label Clinical and Genetic Testing of Patients With Usher Syndrome
This study is aimed to characterize Russian population of Usher patients.
This study is aimed to characterize Russian population of Usher patients. Tasks: Stage 1. Formation of the primary cohort of patients. Patients pre-recruiting will be performed based on Deaf-Blind Support Foundation "Con-nection" patient database analysis. Patients with clinically confirmed Usher syndrome will be evaluated according to available data of the clinical examination. Stage 2. Clinical examination of patients. Each patient will undergo the following diagnostic procedures according to the unified protocol: * Visometry (with correction and without correction) * Ophthalmoscopy * Perimetry * Optical coherence tomography * Electroretinography * Visually evoked potentials * Refractometry * Pneumotonometry * Biomicroscopy * Tonal audiometry * Electronic audiometry (ASSR test) * Acoustic impedance measurement * Vestibulometry * Electronystagmography * Any additional examinations and consultations if necessary Medical record will be developed and maintained for each patient consisting results of extended clinical examination. Stage 3. Genetic study of patients. All enrolled patients will undergo single 4 ml peripheral venous blood sampling. DNA will be extracted from leucocytes. DNA samples will be analyzed and placed for long-term storage in liquid nitrogen. Statistical and bioinformatic analysis of detected genetic mutations in the study cohort will be performed.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Federal State Budgetary Institution "Research Center for Medical Genetics"
Moscow, Russia
Deaf-Blind Support Foundation "Con-nection"
Moscow, Russia
State Research Center Burnasyan Federal Medical Biophysical Center Federal Medical-Biological Agency
Moscow, Russia
Scientific and Clinical Center for Otorhinolaryngology of FMBA of Russia
Moscow, Russia
Oftalmic LLC
Moscow, Russia
Autonomous nonprofit organization "Scientific and industrial laboratory "Sensor technology for deafblind"
Moscow, Russia
Start Date
May 17, 2017
Primary Completion Date
April 1, 2018
Completion Date
June 1, 2018
Last Updated
April 3, 2019
28
ACTUAL participants
Lead Sponsor
Sensor Technology for Deafblind
Collaborators
NCT05926583
NCT07174726
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07292987